It was part of a 3m sale of two drugs stocks by the UK's biggest quoted venture investor, as MDY snapped up 1.2% of ProStrakan at 61.5p a share, Thursday's closing price. The shares, which doubled to top 100p between March and August last year, firmed ...
Recent comments
4 years 49 weeks ago
14 years 13 weeks ago
14 years 14 weeks ago
14 years 14 weeks ago
14 years 31 weeks ago
14 years 31 weeks ago
14 years 38 weeks ago
15 years 4 weeks ago
15 years 38 weeks ago
15 years 38 weeks ago